Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2835-2841

  Albertson, Gregory D ^a   Niimi, Masakazu ^a   Cannon, Richard D ^a   Jenkinson, Howard F ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BENOMYL; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; METHOTREXATE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG TRANSPORT; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANSPORT KINETICS;

EID: 0029853191     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2835     Document Type: Article

References (51)

1. Balzi, E., M. Wang, S. Leterme, L. Van Dyck, and A. Goffeau. 1994. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269:2206-2214.
2. Bart-Delabesse, E., P. Boiron, A. Carlotti, and B. Dupont. 1993. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J. Clin. Microbiol. 31:2933-2937.
3. Bennett, J., and S. Grant. 1990. Fluconazole: an overview. Adis International, Langhorne, Pa.
4. Ben-Yaacov, R., S. Knoller, G. A. Caldwell, J. M. Becker, and Y. Koltin. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38:648-652.
5. Berger, S. L., and A. R. Kimmel. 1987. Guide to molecular cloning techniques. Methods Enzymol. 152:20-24.
6. Bodey, G. P. 1988. Fungal infections in cancer patients. Ann. N. Y. Acad. Sci. 544:431-442.
7. Boiron, P., E. Drouhet, B. Dupont, and L. Improvisi. 1987. Entry of ketoconazole into Candida albicans. Antimicrob. Agents Chemother. 31:244-248.
8. Boken, D. J., S. Swindells, and M. G. Rinaldi. 1993. Fluconazole-resistant Candida albicans. Clin. Infect. Dis. 17:1018-1021.
9. Cannon, R. D., K. Niimi, H. F. Jenkinson, and M. G. Shepherd. 1994. Molecular cloning and expression of the Candida albicans β-N-acetylglucosaminidase (HEX1) gene. J. Bacteriol. 176:2640-2647.
10. Coleman, D. C., D. E. Bennett, D. J. Sullivan, P. J. Gallagher, M. C. Henman, D. B. Shanley, and R. J. Russell. 1993. Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit. Rev. Microbiol. 19:61-82.
11. Espinel-Ingroff, A., C. W. J. Kish, T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
12. Fling, M. E., J. Kopf, A. Tamarkin, J. A. Gorman, H. A. Smith, and Y. Koltin, 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:318-329.
13. Fox, R., K. R. Neal, C. L. S. Leen, M. E. Ellis, and B. K. Mandal. 1991. Fluconazole resistant Candida in AIDS. J. Infect. 22:201-204.
14. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
15. T gene. Antimicrob. Agents Chemother. 39:422-426.
16. Higgins, C. F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:67-113.
17. Higgins, C. F. 1995. The ABC of channel regulation. Cell 82:693-696.
18. Hitchcock, C. A. 1993. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 21:1039-1047.
19. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1986. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J. Gen. Microbiol. 132:2421-2431.
20. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1987. Inhibition of 14α-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole. J. Med. Vet. Mycol. 25:329-333.
21. Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
22. Holmes, A. R., R. D. Cannon, and M. G. Shepherd. 1991. Effect of calcium ion uptake on Candida albicans morphology. FEMS Microbiol. Lett. 77:187-194.
23. Howell, S. A., A. I. Mallet, and W. C. Noble. 1990. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains. J. Appl. Bacteriol. 69: 692-696.
24. Jenkinson, H. F. 1996. Ins and outs of antimicrobial resistance: era of the drug pumps. J. Dent. Res. 75:736-742.
25. Johnson, E. M., K. G. Davey, A. Szekely, and D. W. Warnock. 1995. Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. J. Antimicrob. Chemother. 36:787-793.
26. Kelly, R., S. M. Miller, M. B. Kurtz, and D. R. Kirsch. 1987. Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants. Mol. Cell. Biol. 7:199-208.
27. Kitchen, V. S., M. Savage, and J. R. W. Harris. 1991. Candida albicans resistance in AIDS. J. Infect. 22:204-205.
28. Lai, M. H., and D. R. Kirsch. 1989. Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14α-demethylase) from Candida albicans. Nucleic Acids Res. 17:804.
29. Losberger, C., and J. F. Ernst. 1989. Sequence of the Candida albicans gene encoding actin. Nucleic Acids Res. 17:9488.
30. Marger, M. D., and M. H. Saier. 1993. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem. Sci. 18:13-20.
31. +-ATPase from Candida albicans. J. Bacteriol. 173:6826-6836.
32. Newman, S. L., T. P. Flanigan, A. Fisher, M. G. Rinaldi, M. Stein, and K. Vigilante. 1994. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin. Infect. Dis. 19:684-686.
33. Odds, F. C. 1992. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. Antimicrob. Agents Chemother. 36:1727-1737.
34. Odds, F. C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob. Chemother. 31:463-471.
35. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
36. Pfaller, M. A., C. Grant, V. Morthland, and J. Rhine-Chalberg. 1994. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J. Clin. Microbiol. 32:506-509.
37. Pfaller, M. A., J. Rhine-Chalberg, W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32:59-64.
38. Prasad, R., P. De Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans. CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-321.
39. Price, M. F., M. T. LaRocco, and L. O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blond cultures over a 5-year period. Antimicrob. Agents Chemother. 38:1422-1424.
40. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
41. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
42. Ruhnke, M., A. Eigler, I. Tennagen, B. Geiseler, E. Engelmann, and M. Trautmann. 1994. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098.
43. Ryley, J. F., R. G. Wilson, and K. J. Barrett-Bee. 1984. Azole resistance in Candida albicans. Sabouraudia 22:53-63.
44. Sanglard, D., K. Kuchler, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicroh. Agents Chemother. 39:2378-2386.
45. Schmid, J., E. Voss, and D. R. Soll. 1990. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J. Clin. Microbiol. 28:1236-1243.
46. Schmitt, M. E., T. A. Brown, and B. L. Trumpower. 1990. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 18:3091-3092.
47. Shawar, K., V. Paetznick, Z. Witte, L. Garnsey Ensign, E. Anaissie, and M. LaRocco. 1992. Collaborative investigation of broth microdilution and semi-solid agar dilution for in vitro susceptibility testing of Candida albicans. J. Clin. Microbiol. 30:1976-1981.
48. Troillet, N., C. Durussel, J. Bille, M. P. Glauser, and J. P. Chave. 1993. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 12:911-915.
49. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
50. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1995. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microbiol. Lett. 131:337-341.
51. Warnock, D. W., E. M. Johnson, M. D. Richardson, and C. F. H. Vickers. 1983. Modified response to ketoconazole of Candida albicans from a treatment failure. Lancet i:642-643.